CN Stock MarketDetailed Quotes

301207 Hualan Biological Vaccine Inc.

Watchlist
  • 18.48
  • -1.27-6.43%
Market Closed Oct 11 15:00 CST
11.11BMarket Cap14.29P/E (TTM)

Hualan Biological Vaccine Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
71.94%1.26B
45.98%623.99M
6.82%640.98M
-58.40%375.78M
-27.94%734.26M
-77.04%427.45M
356.08%600.04M
45.01%903.26M
116.97%1.02B
--1.86B
Transactional financial assets
-11.52%1.27B
44.47%2.4B
12.63%1.6B
42.37%1.89B
-17.42%1.43B
61.29%1.66B
71.86%1.42B
65.82%1.33B
212.60%1.73B
--1.03B
Notes receivable and accounts receivable
17.26%1.17B
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
--1.21B
-Accounts receivable
17.26%1.17B
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
--1.21B
Other receivables (including interest and dividends)
-81.62%735.4K
-31.78%2.56M
219.16%1.31M
332.65%3.65M
662.36%4M
459.72%3.75M
-79.97%411.02K
-57.82%843.87K
-86.17%524.82K
--670.77K
-Other receivable
-81.62%735.4K
----
219.16%1.31M
----
662.36%4M
----
-79.97%411.02K
----
-71.05%524.82K
----
Advance payment
93.34%48.2M
102.47%43.9M
39.37%28.18M
65.73%28.74M
-38.23%24.93M
-76.38%21.68M
-13.27%20.22M
-53.31%17.34M
-3.26%40.36M
--91.79M
Inventories
-11.16%378.07M
0.05%321.52M
3.78%173.47M
1.70%291.55M
42.36%425.54M
-3.23%321.36M
55.63%167.16M
26.61%286.69M
23.34%298.91M
--332.1M
Receivable financing
--2.06M
----
----
----
----
----
----
----
----
----
Non-current assets due within one year
-17.92%303M
166.77%346.81M
187.28%373.46M
--371.3M
--369.14M
--130M
--130M
----
----
----
Other current assets
-39.56%9.63M
----
610.54%420.39M
----
--15.93M
-97.71%1.87K
59,524.87%59.17M
----
----
--81.74K
Total current assets
10.94%4.44B
30.76%5.31B
24.66%5.23B
9.47%5.04B
-20.11%4.01B
-10.14%4.06B
65.77%4.19B
40.36%4.6B
167.43%5.01B
--4.52B
Non Current assets
Fixed assets
-9.69%1.11B
----
-8.69%1.17B
----
-6.23%1.23B
----
-4.82%1.28B
----
123.46%1.31B
----
Constru in process
24.09%4.09M
----
-0.89%3.23M
----
578.94%3.3M
----
--3.26M
----
-99.89%485.75K
----
Productive biological assets
----
54.95%367.15K
49.03%965.1K
16.26%1.57M
-45.48%349K
-60.08%236.94K
-58.70%647.59K
-46.79%1.35M
0.79%640.15K
--593.62K
Intangible assets
-3.19%19.8M
-3.17%19.96M
-3.14%20.13M
-3.12%20.29M
-3.09%20.45M
-3.07%20.62M
-3.05%20.78M
-3.02%20.94M
-3.00%21.11M
--21.27M
Development expenditure
9.68%27.44M
10.87%26.92M
8.71%26.27M
7.59%25.77M
7.70%25.02M
5.55%24.28M
7.27%24.16M
7.98%23.95M
6.01%23.23M
--23M
Long deferred expense
-43.35%834.63K
-58.29%1.25M
-63.15%1.67M
----
-80.52%1.47M
-72.28%3M
-58.17%4.53M
-38.40%7.59M
--7.56M
--10.83M
Deferred tax assets
8.09%216.47M
6.91%212.59M
4.51%217.97M
6.04%209.38M
1.25%200.28M
4.73%198.84M
14.03%208.56M
14.78%197.46M
4.17%197.8M
--189.86M
Usufruct assets
----
----
----
----
----
----
----
-50.00%1.02M
-44.44%1.28M
--1.53M
Other non current assets
10.03%1.44B
-28.94%1.09B
-0.83%1.33B
26.49%1.3B
88.13%1.31B
134.37%1.53B
230.14%1.34B
456.27%1.03B
307.39%694.71M
--652.14M
Total non current assets
1.07%2.82B
-17.87%2.5B
-3.96%2.77B
7.70%2.77B
23.46%2.79B
36.61%3.04B
44.56%2.88B
73.39%2.57B
57.28%2.26B
--2.22B
Total assets
6.89%7.26B
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
78.97%6.75B
Liabilities
Current liabilities
Short term loan
0.00%300M
0.00%300M
0.00%300.18M
0.00%300M
-40.00%300M
-40.00%300M
-40.02%300.18M
-62.50%300M
66.67%500M
--500M
Notes payable and accounts payable
-21.29%106.42M
-5.33%142.91M
-7.09%116.76M
-14.50%122.07M
-26.07%135.22M
-47.31%150.95M
-32.25%125.67M
2.58%142.77M
38.03%182.9M
--286.51M
-Notes payable
-35.10%12.01M
97.21%19.86M
----
-84.49%3.13M
101.66%18.51M
-81.50%10.07M
-36.61%15.31M
-39.16%20.18M
-84.28%9.18M
--54.45M
-Accounts payable
-19.10%94.41M
-12.66%123.04M
5.80%116.76M
-2.97%118.94M
-32.82%116.7M
-39.29%140.88M
-31.60%110.36M
15.64%122.59M
134.36%173.72M
--232.06M
Contract liabilities
215.82%14.53M
103.91%6.87M
-0.41%2.67M
91.46%6.18M
32.31%4.6M
88.35%3.37M
74.10%2.68M
119.44%3.23M
82.88%3.48M
--1.79M
Salaries payable
----
--45.39K
----
----
--3.54K
----
----
----
----
----
Taxs payable
-16.39%2.07M
-72.26%2.29M
347.32%57.68M
102.92%84.2M
-97.16%2.47M
12.29%8.26M
-49.79%12.89M
-59.15%41.5M
9,015.25%87.22M
--7.35M
Other payable (including interest and dividends)
8.92%877.23M
0.62%1B
10.30%1.21B
4.70%1.22B
-31.90%805.42M
16.84%998.58M
14.85%1.1B
22.04%1.17B
77.41%1.18B
--854.66M
-Dividend payable
--28.55M
----
----
----
----
----
----
----
----
----
-Other payable
5.37%848.67M
----
10.30%1.21B
----
-31.90%805.42M
----
14.85%1.1B
----
77.41%1.18B
----
Non current liabilities due within one year
----
----
----
----
----
----
----
4.75%1.07M
4.75%1.06M
--1.04M
Other current liabilities
216.09%435.72K
104.05%205.92K
0.14%80.09K
93.35%185.28K
36.86%137.84K
88.36%100.91K
75.01%79.97K
117.50%95.83K
82.61%100.72K
--53.57K
Total current liabilities
4.23%1.3B
-0.29%1.46B
9.68%1.69B
4.76%1.73B
-36.25%1.25B
-11.51%1.46B
-8.09%1.54B
-17.38%1.65B
76.79%1.96B
--1.65B
Current liabilities
Deferred tax liabilities
30.94%13.61M
67.62%14.56M
137.44%15.22M
233.73%13.83M
176.34%10.39M
188.80%8.69M
156.71%6.41M
115.77%4.14M
133.62%3.76M
--3.01M
Long term deferred income
-12.62%29.31M
-12.24%30.36M
-11.87%31.42M
-14.01%32.48M
-11.21%33.54M
-13.27%34.6M
-10.61%35.66M
-7.87%37.77M
-7.87%37.77M
--39.89M
Lease liabilities
----
----
----
----
----
----
----
----
-79.53%271.83K
--540.52K
Total non current liabilities
-2.32%42.91M
3.79%44.92M
10.88%46.64M
10.48%46.31M
5.08%43.93M
-0.35%43.28M
-2.61%42.07M
-4.71%41.92M
-4.85%41.81M
--43.44M
Total liabilities
4.01%1.34B
-0.17%1.5B
9.71%1.73B
4.90%1.78B
-35.38%1.29B
-11.23%1.5B
-7.95%1.58B
-17.11%1.7B
73.67%2B
6.83%1.69B
Shareholders equity
Paid-in capital
0.17%601.03M
50.00%600.02M
50.00%600.02M
50.00%600.02M
50.00%600.02M
0.00%400.01M
11.11%400.01M
11.11%400.01M
11.11%400.01M
--400.01M
Capital reserve funds
1.28%2.94B
-5.66%2.92B
-5.62%2.92B
-5.63%2.91B
-5.87%2.9B
0.38%3.1B
251.06%3.09B
250.54%3.08B
250.54%3.08B
--3.08B
Surplus reserve funds
43.07%286.16M
43.07%286.16M
43.07%286.16M
27.44%200.01M
27.44%200.01M
27.44%200.01M
27.44%200.01M
65.71%156.94M
65.71%156.94M
--156.94M
Retained profit
18.42%2.13B
31.47%2.5B
36.16%2.46B
26.23%2.32B
10.22%1.8B
34.84%1.9B
28.10%1.81B
32.97%1.84B
97.85%1.63B
--1.41B
Less:Treasury stock
--38.75M
----
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
7.57%5.92B
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
--5.05B
Total shareholder equity
7.57%5.92B
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
131.40%5.05B
Total liabilityies and equity
6.89%7.26B
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
78.97%6.75B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 71.94%1.26B45.98%623.99M6.82%640.98M-58.40%375.78M-27.94%734.26M-77.04%427.45M356.08%600.04M45.01%903.26M116.97%1.02B--1.86B
Transactional financial assets -11.52%1.27B44.47%2.4B12.63%1.6B42.37%1.89B-17.42%1.43B61.29%1.66B71.86%1.42B65.82%1.33B212.60%1.73B--1.03B
Notes receivable and accounts receivable 17.26%1.17B5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B--1.21B
-Accounts receivable 17.26%1.17B5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B--1.21B
Other receivables (including interest and dividends) -81.62%735.4K-31.78%2.56M219.16%1.31M332.65%3.65M662.36%4M459.72%3.75M-79.97%411.02K-57.82%843.87K-86.17%524.82K--670.77K
-Other receivable -81.62%735.4K----219.16%1.31M----662.36%4M-----79.97%411.02K-----71.05%524.82K----
Advance payment 93.34%48.2M102.47%43.9M39.37%28.18M65.73%28.74M-38.23%24.93M-76.38%21.68M-13.27%20.22M-53.31%17.34M-3.26%40.36M--91.79M
Inventories -11.16%378.07M0.05%321.52M3.78%173.47M1.70%291.55M42.36%425.54M-3.23%321.36M55.63%167.16M26.61%286.69M23.34%298.91M--332.1M
Receivable financing --2.06M------------------------------------
Non-current assets due within one year -17.92%303M166.77%346.81M187.28%373.46M--371.3M--369.14M--130M--130M------------
Other current assets -39.56%9.63M----610.54%420.39M------15.93M-97.71%1.87K59,524.87%59.17M----------81.74K
Total current assets 10.94%4.44B30.76%5.31B24.66%5.23B9.47%5.04B-20.11%4.01B-10.14%4.06B65.77%4.19B40.36%4.6B167.43%5.01B--4.52B
Non Current assets
Fixed assets -9.69%1.11B-----8.69%1.17B-----6.23%1.23B-----4.82%1.28B----123.46%1.31B----
Constru in process 24.09%4.09M-----0.89%3.23M----578.94%3.3M------3.26M-----99.89%485.75K----
Productive biological assets ----54.95%367.15K49.03%965.1K16.26%1.57M-45.48%349K-60.08%236.94K-58.70%647.59K-46.79%1.35M0.79%640.15K--593.62K
Intangible assets -3.19%19.8M-3.17%19.96M-3.14%20.13M-3.12%20.29M-3.09%20.45M-3.07%20.62M-3.05%20.78M-3.02%20.94M-3.00%21.11M--21.27M
Development expenditure 9.68%27.44M10.87%26.92M8.71%26.27M7.59%25.77M7.70%25.02M5.55%24.28M7.27%24.16M7.98%23.95M6.01%23.23M--23M
Long deferred expense -43.35%834.63K-58.29%1.25M-63.15%1.67M-----80.52%1.47M-72.28%3M-58.17%4.53M-38.40%7.59M--7.56M--10.83M
Deferred tax assets 8.09%216.47M6.91%212.59M4.51%217.97M6.04%209.38M1.25%200.28M4.73%198.84M14.03%208.56M14.78%197.46M4.17%197.8M--189.86M
Usufruct assets -----------------------------50.00%1.02M-44.44%1.28M--1.53M
Other non current assets 10.03%1.44B-28.94%1.09B-0.83%1.33B26.49%1.3B88.13%1.31B134.37%1.53B230.14%1.34B456.27%1.03B307.39%694.71M--652.14M
Total non current assets 1.07%2.82B-17.87%2.5B-3.96%2.77B7.70%2.77B23.46%2.79B36.61%3.04B44.56%2.88B73.39%2.57B57.28%2.26B--2.22B
Total assets 6.89%7.26B9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B78.97%6.75B
Liabilities
Current liabilities
Short term loan 0.00%300M0.00%300M0.00%300.18M0.00%300M-40.00%300M-40.00%300M-40.02%300.18M-62.50%300M66.67%500M--500M
Notes payable and accounts payable -21.29%106.42M-5.33%142.91M-7.09%116.76M-14.50%122.07M-26.07%135.22M-47.31%150.95M-32.25%125.67M2.58%142.77M38.03%182.9M--286.51M
-Notes payable -35.10%12.01M97.21%19.86M-----84.49%3.13M101.66%18.51M-81.50%10.07M-36.61%15.31M-39.16%20.18M-84.28%9.18M--54.45M
-Accounts payable -19.10%94.41M-12.66%123.04M5.80%116.76M-2.97%118.94M-32.82%116.7M-39.29%140.88M-31.60%110.36M15.64%122.59M134.36%173.72M--232.06M
Contract liabilities 215.82%14.53M103.91%6.87M-0.41%2.67M91.46%6.18M32.31%4.6M88.35%3.37M74.10%2.68M119.44%3.23M82.88%3.48M--1.79M
Salaries payable ------45.39K----------3.54K--------------------
Taxs payable -16.39%2.07M-72.26%2.29M347.32%57.68M102.92%84.2M-97.16%2.47M12.29%8.26M-49.79%12.89M-59.15%41.5M9,015.25%87.22M--7.35M
Other payable (including interest and dividends) 8.92%877.23M0.62%1B10.30%1.21B4.70%1.22B-31.90%805.42M16.84%998.58M14.85%1.1B22.04%1.17B77.41%1.18B--854.66M
-Dividend payable --28.55M------------------------------------
-Other payable 5.37%848.67M----10.30%1.21B-----31.90%805.42M----14.85%1.1B----77.41%1.18B----
Non current liabilities due within one year ----------------------------4.75%1.07M4.75%1.06M--1.04M
Other current liabilities 216.09%435.72K104.05%205.92K0.14%80.09K93.35%185.28K36.86%137.84K88.36%100.91K75.01%79.97K117.50%95.83K82.61%100.72K--53.57K
Total current liabilities 4.23%1.3B-0.29%1.46B9.68%1.69B4.76%1.73B-36.25%1.25B-11.51%1.46B-8.09%1.54B-17.38%1.65B76.79%1.96B--1.65B
Current liabilities
Deferred tax liabilities 30.94%13.61M67.62%14.56M137.44%15.22M233.73%13.83M176.34%10.39M188.80%8.69M156.71%6.41M115.77%4.14M133.62%3.76M--3.01M
Long term deferred income -12.62%29.31M-12.24%30.36M-11.87%31.42M-14.01%32.48M-11.21%33.54M-13.27%34.6M-10.61%35.66M-7.87%37.77M-7.87%37.77M--39.89M
Lease liabilities ---------------------------------79.53%271.83K--540.52K
Total non current liabilities -2.32%42.91M3.79%44.92M10.88%46.64M10.48%46.31M5.08%43.93M-0.35%43.28M-2.61%42.07M-4.71%41.92M-4.85%41.81M--43.44M
Total liabilities 4.01%1.34B-0.17%1.5B9.71%1.73B4.90%1.78B-35.38%1.29B-11.23%1.5B-7.95%1.58B-17.11%1.7B73.67%2B6.83%1.69B
Shareholders equity
Paid-in capital 0.17%601.03M50.00%600.02M50.00%600.02M50.00%600.02M50.00%600.02M0.00%400.01M11.11%400.01M11.11%400.01M11.11%400.01M--400.01M
Capital reserve funds 1.28%2.94B-5.66%2.92B-5.62%2.92B-5.63%2.91B-5.87%2.9B0.38%3.1B251.06%3.09B250.54%3.08B250.54%3.08B--3.08B
Surplus reserve funds 43.07%286.16M43.07%286.16M43.07%286.16M27.44%200.01M27.44%200.01M27.44%200.01M27.44%200.01M65.71%156.94M65.71%156.94M--156.94M
Retained profit 18.42%2.13B31.47%2.5B36.16%2.46B26.23%2.32B10.22%1.8B34.84%1.9B28.10%1.81B32.97%1.84B97.85%1.63B--1.41B
Less:Treasury stock --38.75M------------------------------------
Shareholders equity without minority interests 7.57%5.92B12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B--5.05B
Total shareholder equity 7.57%5.92B12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B131.40%5.05B
Total liabilityies and equity 6.89%7.26B9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B78.97%6.75B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data